49 results on '"Payne, Lendon G"'
Search Results
2. Water-Soluble Phosphazene Polymers for Parenteral and Mucosal Vaccine Delivery
3. Protein Antigen--Monoclonal Antibody Contact Sites Investigated by Limited Proteolysis of Monoclonal Antibody-Bound Antigen: Protein ``Footprinting''
4. Spray-Coating for Biopharmaceutical Powder Formulations: Beyond the Conventional Scale and Its Application
5. Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization
6. Targeting epidermal Langerhans cells by epidermal powder immunization
7. Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxin
8. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice
9. Peptide induces CD4 +CD25 + and IL-10 + T cells and protection in airway allergy models
10. Multi-antigenic DNA immunization using Herpes Simplex Virus type 2 genomic fragments
11. An antigen-independent but not antigen-specific TH1 response provides protection in the murine airway inflammation model
12. Immune responses to hepatitis B surface antigen following epidermal powder immunization
13. Epidermal powder immunization of mice and monkeys with an influenza vaccine
14. Water-Soluble Phosphazene Polymers for Parenteral and Mucosal Vaccine Delivery
15. Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity
16. Utility of SHIV for testing HIV-1 vaccine candidates in macaques
17. Characterization of the IFN-γ T-cell responses to immediate early antigens in humans with genital herpes
18. Adjuvantation of epidermal powder immunization
19. [47] Protein footprinting method for studying antigen-antibody interactions and epitope mapping
20. Characterization of the IFN-γ T-cell responses to immediate early antigens in humans with genital herpes
21. Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models
22. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity
23. Influenza Vaccine Powder Formulation Development: Spray‐Freeze‐Drying and Stability Evaluation
24. Pre-clinical and clinical studies of epidermal powder immunization with an influenza vaccine
25. Stabilization of Alum-Adjuvanted Vaccine Dry Powder Formulations: Mechanism and Application
26. Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA Vaccines
27. Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses
28. Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization
29. Synthesis, Physico-Chemical Properties and Immunoadjuvant Activity of Water-Soluble Phosphazene Polyacids
30. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine
31. Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions
32. Hydrolytic degradation of ionically cross-linked polyphosphazene microspheres
33. Controlled release using ionotropic polyphosphazene hydrogels
34. Recombinant-expressed virus-like particle pseudotypes as an approach to vaccine development
35. Characterization of vaccinia virus glycoproteins by monoclonal antibody precipitation
36. Vaccinia Recombinants as Vaccine Vectors
37. The polypeptide composition of vaccinia-infected cell membranes and rifampicin bodies
38. Spray-Coating for Biopharmaceutical Powder Formulations: Beyond the Conventional Scale and Its Application.
39. Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization.
40. Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coliAre Strong Adjuvants for DNA Vaccines
41. Mechanism of Vaccinia Virus Release and Its Specific Inhibition by N1-Isonicotinoyl-N2-3-Methyl-4- Chlorobenzoylhydrazine
42. Mechanism of Vaccinia Virus Release and Its Specific Inhibition by N 1 -Isonicotinoyl- N 2 -3-Methyl-4- Chlorobenzoylhydrazine
43. Polymeric carriers for oral uptake of microparticulates
44. Protein release from polyphosphazene matrices
45. Peptide induces CD4+CD25+ and IL-10+ T cells and protection in airway allergy models
46. Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment.
47. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
48. Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma.
49. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.